Skip to content
Trial Eligibility
Menu

Multiple Sclerosis Clinical Trials near Milwaukee, WI

12 studies for Multiple Sclerosis are recruiting at 15 sites within 50 miles of Milwaukee, Wisconsin, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Multiple Sclerosis trials in the US or all trials near Milwaukee.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Multiple Sclerosis studies enrolling near Milwaukee

Showing 12 studies, nearest first.
  1. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

    NCT06433752

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: TG Therapeutics Investigational Trial Site (Milwaukee, WI); TG Therapeutics Investigational Trial Site (Greenfield, WI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  2. Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

    NCT06846281

    • Phase 3
    • Ages 40 to 70 years
    • Sex: All

    Nearest sites: Medical College of Wisconsin (Milwaukee, WI); Center for Neurological Disorders G (Greenfield, WI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

    NCT04047628

    • Phase 3
    • Ages 18 to 55 years
    • Sex: All

    Nearest site: Medical College of Wisconsin (Milwaukee, WI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  4. High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis

    NCT05735691

    • Interventional
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Marquette University (Milwaukee, WI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  5. Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

    NCT05877963

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: TG Therapeutics Investigational Trial Site (Milwaukee, WI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

    NCT06408259

    • Phase 3
    • Ages 10 to 17 years
    • Sex: All

    Nearest site: Medical College of Wisconsin (Milwaukee, WI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

    NCT06680037

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: TG Therapeutics Investigational Trial Site (Milwaukee, WI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

    NCT06796504

    • Interventional
    • Ages 22 to 60 years
    • Sex: All

    Nearest site: Medical College of Wisconsin (Milwaukee, WI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

    NCT07067463

    • Phase 3
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Medical College of Wisconsin (Milwaukee, WI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

    NCT07224373

    • Phase 1
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Research Site (Milwaukee, WI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

    NCT07325292

    • Phase 3
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Medical College of Wisconsin - Milwaukee Campus- Site Number : 8400038 (Milwaukee, WI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

    NCT04806620

    • Observational
    • Ages 2 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Brain Inflammation Collaborative (Delafield, WI)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Multiple Sclerosis clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.